Evasive Strategies in Rabies Virus Infection

Advances in Virus Research

Volumn 79, Issue , 2011, Pages 33-53

  Lafon, Monique ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Immunoevasion; Rabies virus; Survival signaling pathway; Virus host cell interactions

Indexed keywords

ANIMAL; BOOK; CELL SURVIVAL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGY; NERVOUS SYSTEM; PATHOGENICITY; RABIES VIRUS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIROLOGY;

ANIMALS; CELL SURVIVAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; NERVOUS SYSTEM; RABIES VIRUS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 79956143382     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387040-7.00003-2     Document Type: Book

References (113)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 2002, 298(5594):846-850.
2. Allsopp T.E., Scallan M.F., Williams A., Fazakerley J.K. Virus infection induces neuronal apoptosis: A comparison with trophic factor withdrawal. Cell Death Differ. 1998, 5(1):50-59.
3. Baloul L., Lafon M. Apoptosis and rabies virus neuroinvasion. Biochimie 2003, 85(8):777-788.
4. Baloul L., Camelo S., Lafon M. Up-regulation of Fas ligand (FasL) in the central nervous system: A mechanism of immune evasion by rabies virus. J. Neurovirol. 2004, 10(6):372-382.
5. Barajon I., Serrao G., Arnaboldi F., Opizzi E., Ripamonti G., Balsari A., Rumio C. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J. Histochem. Cytochem. 2009, 57(11):1013-1023.
6. Bechmann I., Galea I., Perry V.H. What is the blood-brain barrier (not)?. Trends Immunol. 2007, 28(1):5-11.
7. Brehin A.-C., Mouries J., Frenkiel M.-P., Dadaglio G., Despres P., Lafon M., Couderc T. Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+ B220- BST-2+ leukocyte population. J. Immunol. 2008, 180(10):6760-6767.
8. Camelo S., Lafage M., Lafon M. Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis. J. Neurovirol. 2000, 6(6):507-518.
9. Cameron J.S., Alexopoulou L., Sloane J.A., DiBernardo A.B., Ma Y., Kosaras B., Flavell R., Strittmatter S.M., Volpe J., Sidman R., Vartanian T. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 2007, 27(47):13033-13041.
10. Chen S., Short J.A., Young D.F., Killip M.J., Schneider M., Goodbourn S., Randall R.E. Heterocellular induction of interferon by negative-sense RNA viruses. Virology 2010, 407(2):247-255.
11. Chiron D., Pellat-Deceunynck C., Amiot M., Bataille R., Jego G. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production. J. Immunol. 2009, 182(7):4471-4478.
12. Daffis S., Samuel M.A., Suthar M.S., Gale M., Diamond M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 2008, 82(21):10349-10358.
13. Davoust N., Vuaillat C., Androdias G., Nataf S. From bone marrow to microglia: Barriers and avenues. Trends Immunol. 2008, 29(5):227-234.
14. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., Michiels T. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. USA 2006, 103(20):7835-7840.
15. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., Lennon V.A., Celis E., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat. Med. 2002, 8(8):793-800.
16. Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr. Pharm. Des. 2008, 14(16):1555-1565.
17. Faber M., Pulmanausahakul R., Hodawadekar S.S., Spitsin S., McGettigan J.P., Schnell M.J., Dietzschold B. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J. Virol. 2002, 76(7):3374-3381.
18. Faber M., Bette M., Preuss M.A., Pulmanausahakul R., Rehnelt J., Schnell M.J., Dietzschold B., Weihe E. Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J. Virol. 2005, 79(24):15405-15416.
19. Faul E.J., Wanjalla C.N., Suthar M.S., Gale M., Wirblich C., Schnell M.J. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 2010, 6(7):e1001016.
20. Fu Z.F., Weihe E., Zheng Y.M., Schafer M.K., Sheng H., Corisdeo S., Rauscher F.J., Koprowski H., Dietzschold B. Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J. Virol. 1993, 67(11):6674-6681.
21. Furr S.R., Chauhan V.S., Sterka D., Grdzelishvili V., Marriott I. Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus. J. Neurovirol. 2008, 14(6):503-513.
22. Galelli A., Baloul L., Lafon M. Abortive rabies virus central nervous infection is controlled by T lymphocyte local recruitment and induction of apoptosis. J. Neurovirol. 2000, 6(5):359-372.
23. Girard S., Couderc T., Destombes J., Thiesson D., Delpeyroux F., Blondel B. Poliovirus induces apoptosis in the mouse central nervous system. J. Virol. 1999, 73(7):6066-6072.
24. Goethals S., Ydens E., Timmerman V., Janssens S. Toll-like receptor expression in the peripheral nerve. Glia 2010, 58(14):1701-1709.
25. Gratas C., Tohma Y., Barnas C., Taniere P., Hainaut P., Ohgaki H. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res. 1998, 58(10):2057-2062.
26. Griffiths M., Neal J.W., Gasque P. Innate immunity and protective neuroinflammation: New emphasis on the role of neuroimmune regulatory proteins. Int. Rev. Neurobiol. 2007, 82:29-55.
27. Guigoni C., Coulon P. Rabies virus is not cytolytic for rat spinal motoneurons in vitro. J. Neurovirol. 2002, 8(4):306-317.
28. Harris B.Z., Lim W.A. Mechanism and role of PDZ domains in signaling complex assembly. J. Cell Sci. 2001, 114(Pt 18):3219-3231.
29. Hemachudha T., Wacharapluesadee S., Mitrabhakdi E., Wilde H., Morimoto K., Lewis R.A. Pathophysiology of human paralytic rabies. J. Neurovirol. 2005, 11(1):93-100.
30. Hicks D.J., Nunez A., Healy D.M., Brookes S.M., Johnson N., Fooks A.R. Comparative pathological study of the murine brain after experimental infection with classical rabies virus and European bat lyssaviruses. J. Comp. Pathol. 2009, 140(2-3):113-126.
31. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., Blom B., Homola M.E., Streit W.J., Brown M.H., Barclay A.N., Sedgwick J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290(5497):1768-1771.
32. Hooper D.C., Morimoto K., Bette M., Weihe E., Koprowski H., Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 1998, 72(5):3711-3719.
33. Hooper D.C., Phares T.W., Fabis M.J., Roy A. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl. Trop. Dis. 2009, 3(10):e535.
34. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., Hartmann G. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314(5801):994-997.
35. Hou S.W., Zhi H.Y., Pohl N., Loesch M., Qi X.M., Li R.S., Basir Z., Chen G. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction. Cancer Res. 2010, 70(7):2901-2910.
36. Irwin D.J., Wunner W.H., Ertl H.C., Jackson A.C. Basis of rabies virus neurovirulence in mice: Expression of major histocompatibility complex class I and class II mRNAs. J. Neurovirol. 1999, 5(5):485-494.
37. Ito N., Moseley G.W., Blondel D., Shimizu K., Rowe C.L., Ito Y., Masatani T., Nakagawa K., Jans D.A., Sugiyama M. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J. Virol. 2010, 84(13):6699-6710.
38. Iwasaki Y., Gerhard W., Clark H.F. Role of host immune response in the development of either encephalitic or paralytic disease after experimental rabies infection in mice. Infect. Immun. 1977, 18(1):220-225.
39. Jackson A.C., Rossiter J.P., Lafon M. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J. Neurovirol. 2006, 12(3):229-234.
40. Jackson A.C., Scott C.A., Owen J., Weli S.C., Rossiter J.P. Therapy with minocycline aggravates experimental rabies in mice. J. Virol. 2007, 81(12):6248-6253.
41. Jackson A.C., Randle E., Lawrance G., Rossiter J.P. Neuronal apoptosis does not play an important role in human rabies encephalitis. J. Neurovirol. 2008, 14(5):368-375.
42. Jackson A.C., Kammouni W., Zherebitskaya E., Fernyhough P. Role of oxidative stress in rabies virus infection of adult mouse dorsal root ganglion neurons. J. Virol. 2010, 84(9):4697-4705.
43. Johnston J.A., Ward C.L., Kopito R.R. Aggresomes: A cellular response to misfolded proteins. J. Cell Biol. 1998, 143(7):1883-1898.
44. Juntrakul S., Ruangvejvorachai P., Shuangshoti S., Wacharapluesadee S., Hemachudha T. Mechanisms of escape phenomenon of spinal cord and brainstem in human rabies. BMC Infect. Dis. 2005, 5:104.
45. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., Engle M., Diamond M.S. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 2005, 79(17):11457-11466.
46. Klingen Y., Conzelmann K.K., Finke S. Double-labeled rabies virus: Live tracking of enveloped virus transport. J. Virol. 2008, 82(1):237-245.
47. Kojima D., Park C.H., Satoh Y., Inoue S., Noguchi A., Oyamada T. Pathology of the spinal cord of C57BL/6J mice infected with rabies virus (CVS-11 strain). J. Vet. Med. Sci. 2009, 71(3):319-324.
48. Kojima D., Park C.H., Tsujikawa S., Kohara K., Hatai H., Oyamada T., Noguchi A., Inoue S. Lesions of the central nervous system induced by intracerebral inoculation of BALB/c mice with rabies virus (CVS-11). J. Vet. Med. Sci. 2010, 72(8):1011-1016.
49. Kolodziejska K.E., Burns A.R., Moore R.H., Stenoien D.L., Eissa N.T. Regulation of inducible nitric oxide synthase by aggresome formation. Proc. Natl. Acad. Sci. USA 2005, 102(13):4854-4859.
50. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000, 10(12):524-530.
51. Kristensson K., Dastur D.K., Manghani D.K., Tsiang H., Bentivoglio M. Rabies: Interactions between neurons and viruses. A review of the history of Negri inclusion bodies. Neuropathol. Appl. Neurobiol. 1996, 22(3):179-187.
52. Lafon M. Modulation of the immune response in the nervous system by rabies virus. Curr. Top. Microbiol. Immunol. 2005, 289:239-258.
53. Lafon M. Immune evasion, a critical strategy for rabies virus. Dev. Biol. (Basel) 2008, 131:413-419.
54. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., Moreau P., Rouas-Freiss N., Carosella E.D. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J. Virol. 2005, 79(24):15226-15237.
55. Lafon M., Megret F., Lafage M., Prehaud C. The innate immune facet of brain: Human neurons express TLR-3 and sense viral dsRNA. J. Mol. Neurosci. 2006, 29(3):185-194.
56. Lafon M., Megret F., Meuth S.G., Simon O., Velandia Romero M.L., Lafage M., Chen L., Alexopoulou L., Flavell R.A., Prehaud C., Wiendl H. Detrimental contribution of the immuno-inhibitor b7-h1 to rabies virus encephalitis. J. Immunol. 2008, 180(11):7506-7515.
57. Lahaye X., Vidy A., Pomier C., Obiang L., Harper F., Gaudin Y., Blondel D. Functional characterization of Negri bodies (NBs) in rabies virus infected cells: Evidence that NBs are sites of viral transcription and replication. J. Virol. 2009, 83(16):7948-7958.
58. Laothamatas J., Wacharapluesadee S., Lumlertdacha B., Ampawong S., Tepsumethanon V., Shuangshoti S., Phumesin P., Asavaphatiboon S., Worapruekjaru L., Avihingsanon Y., Israsena N., Lafon M., et al. Furious and paralytic rabies of canine origin: Neuroimaging with virological and cytokine studies. J. Neurovirol. 2008, 14(2):119-129.
59. Lathia J.D., Okun E., Tang S.C., Griffioen K., Cheng A., Mughal M.R., Laryea G., Selvaraj P.K., ffrench-Constant C., Magnus T., Arumugam T.V., Mattson M.P. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J. Neurosci. 2008, 28(51):13978-13984.
60. Lee H.J., Zheng J.J. PDZ domains and their binding partners: Structure, specificity, and modification. Cell. Commun. Signal. 2010, 8:8.
61. Liu J., Hamrouni A., Wolowiec D., Coiteux V., Kuliczkowski K., Hetuin D., Saudemont A., Quesnel B. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood 2007, 110(1):296-304.
62. Loh S.H., Francescut L., Lingor P., Bahr M., Nicotera P. Identification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screen. Cell Death Differ. 2008, 15(2):283-298.
63. Masatani T., Ito N., Shimizu K., Ito Y., Nakagawa K., Sawaki Y., Koyama H., Sugiyama M. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J. Virol. 2010, 84(8):4002-4012.
64. Megret F., Prehaud C., Lafage M., Batejat C., Escriou N., Lay S., Thoulouze M.I., Lafon M. Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis. Vaccine 2005, 23:5342-5350.
65. Megret F., Prehaud C., Lafage M., Moreau P., Rouas-Freiss N., Carosella E.D., Lafon M. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum. Immunol. 2007, 68(4):294-302.
66. Meldolesi J. Neurite outgrowth: This process, first discovered by Santiago Ramon y Cajal, is sustained by the exocytosis of two distinct types of vesicles. Brain. Res. Rev. 2010, 66(1-2):246-255.
67. Menager P., Roux P., Megret F., Bourgeois J.P., Le Sourd A.M., Danckaert A., Lafage M., Prehaud C., Lafon M. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog. 2009, 5(2):e1000315.
68. Meuth S.G., Simon O.J., Grimm A., Melzer N., Herrmann A.M., Spitzer P., Landgraf P., Wiendl H. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing. J. Neuroimmunol. 2008, 194(1-2):62-69.
69. Montano-Hirose J.A., Lafage M., Weber P., Badrane H., Tordo N., Lafon M. Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice. Vaccine 1993, 11(12):1259-1266.
70. Morimoto K., Hooper D.C., Spitsin S., Koprowski H., Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 1999, 73(1):510-518.
71. Niederkorn J.Y. See no evil, hear no evil, do no evil: The lessons of immune privilege. Nat. Immunol. 2006, 7(4):354-359.
72. Nourry C., Grant S.G., Borg J.P. PDZ domain proteins: Plug and play. Sci. STKE 2003, 2003(179):RE7.
73. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173(6):3916-3924.
74. Park C.H., Kondo M., Inoue S., Noguchi A., Oyamada T., Yoshikawa H., Yamada A. The histopathogenesis of paralytic rabies in six-week-old C57BL/6J mice following inoculation of the CVS-11 strain into the right triceps surae muscle. J. Vet. Med. Sci. 2006, 68(6):589-595.
75. Peltier D.C., Simms A., Farmer J.R., Miller D.J. Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J. Immunol. 2010, 184(12):7010-7021.
76. Phares T.W., Kean R.B., Mikheeva T., Hooper D.C. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol. 2006, 176(12):7666-7675.
77. Prehaud C., Lay S., Dietzschold B., Lafon M. Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. J. Virol. 2003, 77(19):10537-10547.
78. Prehaud C., Megret F., Lafage M., Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 2005, 79(20):12893-12904.
79. Prehaud C., Wolff N., Terrien E., Lafage M., Megret F., Babault N., Cordier F., Tan G.S., Maitrepierre E., Menager P., Chopy D., Hoos S., et al. Attenuation of rabies virulence: Takeover by the cytoplasmic domain of its envelope protein. Sci. Signal. 2010, 3(105):ra5.
80. Pulko V., Liu X., Krco C.J., Harris K.J., Frigola X., Kwon E.D., Dong H. TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination. J. Immunol. 2009, 183(6):3634-3641.
81. Randall R.E., Goodbourn S. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89(Pt 1):1-47.
82. Rieder M., Conzelmann K.K. Rhabdovirus evasion of the interferon system. J. Interferon Cytokine Res. 2009, 29(9):499-509.
83. Rossiter J.P., Hsu L., Jackson A.C. Selective vulnerability of dorsal root ganglia neurons in experimental rabies after peripheral inoculation of CVS-11 in adult mice. Acta Neuropathol. 2009, 118(2):249-259.
84. Rouas-Freiss N., Moreau P., Menier C., Carosella E.D. HLA-G in cancer: A way to turn off the immune system. Semin. Cancer Biol. 2003, 13(5):325-336.
85. Roy A., Hooper D.C. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J. Virol. 2007, 81(15):7993-7998.
86. Roy A., Phares T.W., Koprowski H., Hooper D.C. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J. Virol. 2007, 81(3):1110-1118.
87. Schafernak K.T., Bigio E.H. West Nile virus encephalomyelitis with polio-like paralysis & nigral degeneration. Can. J. Neurol. Sci. 2006, 33(4):407-410.
88. Schreiner B., Mitsdoerffer M., Kieseier B.C., Chen L., Hartung H.P., Weller M., Wiendl H. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: Relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 2004, 155(1-2):172-182.
89. Scott C.A., Rossiter J.P., Andrew R.D., Jackson A.C. Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice. J. Virol. 2008, 82(1):513-521.
90. Shankar V., Kao M., Hamir A.N., Sheng H., Koprowski H., Dietzschold B. Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J. Virol. 1992, 66(2):992-998.
91. Sheng M., Sala C. PDZ domains and the organization of supramolecular complexes. Annu. Rev. Neurosci. 2001, 24:1-29.
92. Sommereyns C., Paul S., Staeheli P., Michiels T. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 2008, 4(3):e1000017.
93. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 2007, 104(34):13798-13803.
94. Tang S.C., Lathia J.D., Selvaraj P.K., Jo D.G., Mughal M.R., Cheng A., Siler D.A., Markesbery W.R., Arumugam T.V., Mattson M.P. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 2008, 213(1):114-121.
95. Thoulouze M.I., Lafage M., Montano-Hirose J.A., Lafon M. Rabies virus infects mouse and human lymphocytes and induces apoptosis. J. Virol. 1997, 71(10):7372-7380.
96. Thoulouze M.I., Lafage M., Yuste V.J., Baloul L., Edelman L., Kroemer G., Israel N., Susin S.A., Lafon M. High level of Bcl-2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces long-term infection. Virology 2003, 314(2):549-561.
97. Tobiume M., Sato Y., Katano H., Nakajima N., Tanaka K., Noguchi A., Inoue S., Hasegawa H., Iwasa Y., Tanaka J., Hayashi H., Yoshida S., et al. Rabies virus dissemination in neural tissues of autopsy cases due to rabies imported into Japan from the Philippines: Immunohistochemistry. Pathol. Int. 2009, 59(8):555-566.
98. Tsunoda I., Tanaka T., Saijoh Y., Fujinami R.S. Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am. J. Pathol. 2007, 171(5):1563-1575.
99. Ugolini G. Specificity of rabies virus as a transneuronal tracer of motor networks: Transfer from hypoglossal motoneurons to connected second-order and higher order central nervous system cell groups. J. Comp. Neurol. 1995, 356(3):457-480.
100. Ugolini G. Advances in viral transneuronal tracing. J. Neurosci. Methods 2010, 194(1):2-20.
101. Vuaillat C., Varrin-Doyer M., Bernard A., Sagardoy I., Cavagna S., Chounlamountri I., Lafon M., Giraudon P. High CRMP2 expression in peripheral T lymphocytes is associated with recruitment to the brain during virus-induced neuroinflammation. J. Neuroimmunol. 2008, 193(1-2):38-51.
102. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10(12):1366-1373.
103. Wang Z.W., Sarmento L., Wang Y., Li X.Q., Dhingra V., Tseggai T., Jiang B., Fu Z.F. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 2005, 79(19):12554-12565.
104. Weihe E., Bette M., Preuss M.A., Faber M., Schafer M.K., Rehnelt J., Schnell M.J., Dietzschold B. Role of virus-induced neuropeptides in the brain in the pathogenesis of rabies. Dev. Biol. (Basel) 2008, 131:73-81.
105. Weiland F., Cox J.H., Meyer S., Dahme E., Reddehase M.J. Rabies virus neuritic paralysis: Immunopathogenesis of nonfatal paralytic rabies. J. Virol. 1992, 66(8):5096-5099.
106. Wiktor T.J., Macfarlan R.I., Reagan K.J., Dietzschold B., Curtis P.J., Wunner W.H., Kieny M.P., Lathe R., Lecocq J.P., Mackett M., et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 1984, 81(22):7194-7198.
107. Wright G.J., Puklavec M.J., Willis A.C., Hoek R.M., Sedgwick J.D., Brown M.H., Barclay A.N. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 2000, 13(2):233-242.
108. Wunner W.H., Dietzschold B., Curtis P.J., Wiktor T.J. Rabies subunit vaccines. J. Gen. Virol. 1983, 64(Pt 8):1649-1656.
109. Xiang Z.Q., Knowles B.B., McCarrick J.W., Ertl H.C. Immune effector mechanisms required for protection to rabies virus. Virology 1995, 214(2):398-404.
110. Yanagisawa J., Takahashi M., Kanki H., Yano-Yanagisawa H., Tazunoki T., Sawa E., Nishitoba T., Kamishohara M., Kobayashi E., Kataoka S., Sato T. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 1997, 272(13):8539-8545.
111. Yang L., Voytek C.C., Margolis T.P. Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J. Virol. 2000, 74(1):209-217.
112. Zhang B., Chan Y.K., Lu B., Diamond M.S., Klein R.S. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 2008, 180(4):2641-2649.
113. Zhou L., Wang X., Wang Y.J., Zhou Y., Hu S., Ye L., Hou W., Li H., Ho W.Z. Activation of toll-like receptor-3 induces interferon-lambda expression in human neuronal cells. Neuroscience 2009, 159(2):629-637.